Sedana Medical AB (publ)
STO:SEDANA

Watchlist Manager
Sedana Medical AB (publ) Logo
Sedana Medical AB (publ)
STO:SEDANA
Watchlist
Price: 8.76 SEK -1.02% Market Closed
Market Cap: 870.2m SEK

During the last 3 months Sedana Medical AB (publ) insiders bought 101k SEK , and have not sold any shares. The stock price has dropped by 54% over this period (open performance analysis).

The last transaction was made on Mar 18, 2025 by Christoffer Björn Rosenblad (Chief Financial Officer) , who bought 101k SEK worth of SEDANA shares.

Last Transactions:
Christoffer Björn Rosenblad
Chief Financial Officer
kr+101k
Stefan Krisch
Interim CEO
kr+100.6k
Christoffer Björn Rosenblad
Chief Financial Officer
kr-111.8k
Christoffer Björn Rosenblad
Chief Financial Officer
kr+118.7k
Jessica Westfal
Vice President Market Access
kr+62.3k
Claus Bjerre
Chief Executive Officer (CEO)
kr+1.3m
Claus Bjerre
Chief Executive Officer (CEO)
kr+1.5m
Peter Sackey
Chief Medical Officer
kr+65.2k
Stefan Krisch
Interim CEO
kr+147.2k
Jens Viebke
Chief Executive Officer
kr+466k
Stefan Krisch
Interim CEO
kr+138k
Stefan Krisch
Interim CEO
kr+117.3k
Johannes Doll
CEO
kr+1.8m
Johan Spetz
Chief Financial Officer
kr+1.8m
Christoffer Björn Rosenblad
Chief Financial Officer
kr+232k
Christoffer Björn Rosenblad
Chief Financial Officer
kr-115k
Quang Thong Ngo
Chief Financial Officer (CFO)
kr+64.3k
Hilde Furberg
Board Member
kr+64.3k
Christoffer Björn Rosenblad
Chief Financial Officer
kr+161.4k
Johannes Doll
CEO
kr+209.5k
Johan Spetz
Chief Financial Officer
kr+223.6k
Johannes Doll
CEO
kr+1m
Ola Gunnar Magnusson
Chairman of the Board
kr-2.9m
View All Transactions

During the last 3 months Sedana Medical AB (publ) insiders bought 101k SEK , and have not sold any shares. The stock price has dropped by 54% over this period (open performance analysis).

The last transaction was made on Mar 18, 2025 by Christoffer Björn Rosenblad (Chief Financial Officer) , who bought 101k SEK worth of SEDANA shares.

Sold
0-3
months
0 SEK
0
3-6
months
111.8k SEK
1
6-9
months
0 SEK
0
9-12
months
0 SEK
0
Bought
0-3
months
1
101k SEK
3-6
months
5
3.3m SEK
6-9
months
2
721.3k SEK
9-12
months
No Insider Transactions
0
0 SEK

Sedana Medical AB (publ)
Insider Trading Chart

Sedana Medical AB (publ)
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Sedana Medical AB (publ)
Last Insider Transactions

Global
Insiders Monitor

Sedana Medical AB (publ)
Glance View

Market Cap
870.2m SEK
Industry
Health Care

Sedana Medical AB is a medical technology company, which engages in the development, manufacture, and sale of medical devices and drug development for future projects around AnaConDa. The company is headquartered in Danderyd, Stockholm. The company went IPO on 2017-06-21. The company develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.

SEDANA Intrinsic Value
12.75 SEK
Undervaluation 31%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top